4//SEC Filing
Beddingfield III Frederick 4
Accession 0001562180-19-000146
CIK 0001656328other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:11 PM ET
Size
14.0 KB
Accession
0001562180-19-000146
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Award
Common Stock
2019-01-01+187,500→ 791,662 total - Award
Stock Options (Right to buy)
2019-01-01+40,968→ 40,968 totalExercise: $2.32From: 2019-01-01Exp: 2029-01-01→ Common Stock (40,968 underlying) - Award
Stock Options (Right to buy)
2019-01-01+93,750→ 93,750 totalExercise: $2.32Exp: 2029-01-01→ Common Stock (93,750 underlying) - Award
Stock Options (Right to buy)
2019-01-01+93,750→ 187,500 totalExercise: $2.32Exp: 2029-01-01→ Common Stock (93,750 underlying)
Holdings
- 112,614(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Award of restricted stock units ("RSUs") granted under the Issuer's 2017 Incentive Award Plan. Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting. The award vests as to twenty-five percent (25%) of the total number of RSUs on July 1, 2019, twenty-five percent (25%) of the total number of RSUs on January 1, 2020, and the remaining fifty percent (50%) of the total number of RSUs on the second anniversary, in each case, subject to the Reporting Person's continued employment or service relationship with the Issuer through the applicable vesting date.
- [F2]Includes a total of 2,916 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]The shares are directly held by the Beddingfield Family Trust.
- [F4]Twenty percent (20%) of the shares subject to the option vest and become exercisable upon satisfaction of one performance-based milestone, forty percent (40%) of the shares vest and become exercisable upon satisfaction of a second performance-based milestone, and the remaining forty percent (40%) of the shares vest and become exercisable upon satisfaction of a third performance-based milestone, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- [F5]Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on July 1,2019, twenty-five percent (25%) of the shares vest and become exercisable on January 1, 2020, and the remaining shares vest and become exercisable in 12 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Entity typeother
Related Parties
1- filerCIK 0001573074
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:11 PM ET
- Size
- 14.0 KB